Kaela M Bynoe (Kaela Bynoe)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Oxide Nanoparticles

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Kiranj Chaudagar, Hanna M Hieromnimon, Anne Kelley, Brian Labadie, Jordan S Shafran, Srikrishnan Rameshbabu, Catherine Drovetsky, Kaela M Bynoe, Solanki Aniruddhsingh, Erica Markiewicz, Xiaobing Fan, Massimo Loda, Akash Patnaik
Suppression of tumor cell lactate-generating signaling pathways eradicates murine PTEN/p53-deficient aggressive-variant prostate cancer via macrophage phagocytosis. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Kiranj Chaudagar, Hanna M Hieromnimon, Rimpi Khurana, Brian Labadie, Taghreed Hirz, Shenglin Mei, Raisa Hasan, Jordan S Shafran, Anne Kelley, Eva Apostolov, Ghamdan Al-Eryani, Kate Harvey, Srikrishnan Rameshbabu, Mayme Loyd, Kaela M Bynoe, Catherine Drovetsky, Solanki Aniruddhsingh, Erica Markiewicz, Marta Zamora, Xiaobing Fan, Stephan C Schürer, Alexander Swarbrick, David Brian Sykes, Akash Patnaik
Reversal of lactate and PD-1-mediated macrophage immunosuppression controls growth of PTEN/p53-deficient prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Kiranj Kishor Chaudagar, Natalie Landon-Brace, Aniruddh Solanki, Hanna M Hieromnimon, Emma Hegermiller, Wen Li, Yue Shao, John Joseph, Devan J Wilkins, Kaela M Bynoe, Xiang-Ling Li, John Gerard Clohessy, Soumya Ullas, Jeffrey M Karp, Akash Patnaik
Cabozantinib Unlocks Efficient In Vivo Targeted Delivery of Neutrophil-Loaded Nanoparticles into Murine Prostate Tumors. Molecular cancer therapeutics 20 (2) (2020)